Samina Bari

Samina Bari is the Senior Vice President, Corporate Affairs of Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies. With more than 25 years of experience and her deep understanding of how to articulate business value to deliver outcome-driven results, Bari has a proven track record of creating compelling company narratives that have resulted in high-value acquisitions of publicly traded pharmaceutical companies.
Her extensive experience in corporate communications, change management and public affairs at Fortune 500, public and private companies, and blue chip agencies has led to career highlights including overseeing 10 pharmaceutical product launches, developing the national “Go Red for Women” campaign with the American Heart Association while at Pfizer, managing LIPITOR, the world’s best-selling medication in history, and helping to launch IMRUVICA, one of the most successful oral oncology drug launches.